Business
Novartis announces plans to build flagship manufacturing hub in North Carolina
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced $23 billion investment in US infrastructure East Hanover, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a ne
About this update from Novartis Ag
[{"type":"image","alt":"Novartis Pharma AG","displaySize":"","headline":null,"caption":"Novartis Pharma AG","className":"","disableSlideshowImg":false,"size":{"original":{"width":287,"height":55,"url":"https://media.zenfs.com/en/globenewswire.com/838a2f0cbe482ce95bb28a161721a308"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jVHT.jc1r.9_PBg7JQVa4A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/838a2f0cbe482ce95bb28a161721a308","width":287,"height":55}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030","length":128,"tagName":"p"}]},{"val":[{"type":"text","content":"Enables manufacturing of medicines across company’s main therapeutic areas in one geographic location","length":101,"tagName":"p"}]},{"val":[{"type":"text","content":"Marks latest milestone in company’s previously announced $23 billion investment in US infrastructure","length":100,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":329,"olType":false},{"type":"text","content":"East Hanover, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in the US and delivered to patients across the country at scale.","length":418,"tagName":"p"},{"type":"text","content":"This announcement is part of Novartis’ $23 billion investment in US-based infrastructure over the next five years, designed to increase manufacturing capacity and enable 100% of the company's key medicines to be produced end-to-end in the US.","length":246,"tagName":"p"},{"type":"text","content":"As part of this flagship hub in North Carolina, Novartis will:","length":62,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Build a new site in Durham with the construction of two new facilities dedicated to manufacturing biologics and sterile packaging","length":129,"tagName":"p"}]},{"val":[{"type":"text","content":"Build a new site in Morrisville with one facility for the production of solid dosage tablets and capsules, i...